Posts | Comments | Contact



Neurocrine Biosciences, Inc. (NASD:NBIX) Seasonal Chart

Neurocrine Biosciences, Inc. (NASD:NBIX) Seasonality

NBIX Relative to the S&P 500
NBIX Relative to the S&P 500

NBIX Relative to the Sector
NBIX Relative to the Sector

Monthly Seasonal Neurocrine Biosciences, Inc. (NASD:NBIX)

Seasonal Chart Analysis

Analysis of the Neurocrine Biosciences, Inc. (NASD:NBIX) seasonal charts above shows that a Buy Date of August 6 and a Sell Date of November 11 has resulted in a geometric average return of 5.56% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 5.76% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...